Adrenomedullin contributes to vascular hyporeactivity in cirrhotic rats with ascites via a release of nitric oxide

References

• Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151–7.
   PubMed Web of Science ®Google Scholar
• Claria J, Jimenez W, Ros J, Asbert M, Castro A, Arroyo V, et al. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology 1992;15:343–9.
   PubMed Web of Science ®Google Scholar
• Niederberger M, Martin PY, Gines P, Morris K, Tsai P, Xu DL, et al. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology 1995;109:1624–30.
   PubMed Web of Science ®Google Scholar
• Henriksen JH, Moller S, Schifter S, Bendtsen F. Increased arterial compliance in decompensated cirrhosis. J Hepatol 1999; 31:712–8.
   PubMed Web of Science ®Google Scholar
• Henriksen JH, Moller S, Schifter S, Abrahamsen J, Becker U. High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems. Gut 2001;49:112–8.
   Google Scholar
• Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol 2003;38:S69–S89.
   Google Scholar
• Bosch J, Abraldes JG, Groszmann R. Current management of portal hypertension. J Hepatol 2003;38:S54–S68.
   Google Scholar
• Hadoke PW, Hayes PC. In vitro evidence for vascular hyporesponsiveness in clinical and experimental cirrhosis. Pharmacol Ther 1997;75:51–68.
   PubMed Web of Science ®Google Scholar
• Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 1992;103:235–9.
   PubMed Web of Science ®Google Scholar
• Weigert AL, Martin PY, Niederberger M, Higa EM, McMurtry IF, Gines P, et al. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats. Hepatology 1995;22:1856–62.
   PubMedGoogle Scholar
• Thurston M, Laragh JH. Prior receptor occupancy as a determinant of the pressor activity of infused angiotensin II in the rat. Circ Res 1975;36:113–7.
   PubMed Web of Science ®Google Scholar
• Tazi KA, Moreau R, Heller J, Poirel O, Lebrec D. Changes in protein kinase C isoforms in association with vascular hypor-eactivity in cirrhotic rat aortas. Gastroenterology 2000;119:201–10.
   Google Scholar
• Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993;192:553–60.
   PubMed Web of Science ®Google Scholar
• Shimekake Y, Nagata K, Ohta S, Kambayashi Y, Teraoka H, Kitamura K, et al. Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in bovine aortic endothelial cells. J Biol Chem 1995;270: 4412–7.
   PubMed Web of Science ®Google Scholar
• Hirata Y, Hayakawa H, Suzuki Y, Suzuki E, Ikenouchi H, Kohmoto O, et al. Mechanisms of adrenomedullin-induced vasodilation in the rat kidney. Hypertension 1995;25:790–5.
   PubMedGoogle Scholar
• Hayakawa H, Hirata Y, Kakoki M, Suzuki Y, Nishimatsu H, Nagata D, et al. Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat. Hypertension 1999;33:689–93.
   PubMedGoogle Scholar
• Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, et al. Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995;207: 25–32.
   PubMed Web of Science ®Google Scholar
• Sugo S, Minamino N, Shoji H, Kangawa K, Matsuo H. Effects of vasoactive substances and cAMP related compounds on adrenomedullin production in cultured vascular smooth muscle cells. FEBS Lett 1995;369:311–4.
   Google Scholar
• Chun TH, Itoh H, Ogawa Y, Tamura N, Takaya K, Igaki T, et al. Shear stress augments expression of C-type natriuretic peptide and adrenomedullin. Hypertension 1997;29:1296–302.
   PubMed Web of Science ®Google Scholar
• Fukui H, Brauner B, Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 1991;12:162–9.
   PubMed Web of Science ®Google Scholar
• Deviere J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 1990; 11:628–34.
   PubMed Web of Science ®Google Scholar
• Kojima H, Tsujimoto T, Uemura M, Takaya A, Okamoto S, Ueda S, et al. Significance of increased plasma adrenomedullin concentration in patients with cirrhosis. J Hepatol 1998;28:840–6.
   PubMed Web of Science ®Google Scholar
• Guevara M, Gines P, Jimenez W, Sort P, Fernandez-Esparrach G, Escorsell A, et al. Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems. Gastroenterology 1998;114:336–43.
   Google Scholar
• Fernandez-Rodriguez CM, Prada IR, Prieto J, Montuenga LM, Elssasser T, Quiroga J, et al. Circulating adrenomedullin in cirrhosis: relationship to hyperdynamic circulation. J Hepatol 1998;29:250–6.
   Google Scholar
• Genesca J, Gonzalez A, Catalan R, Segura R, Martinez M, Esteban R, et al. Adrenomedullin, a vasodilator peptide implicated in hemodynamic alterations of liver cirrhosis: relationship to nitric oxide. Dig Dis Sci 1999;44:372–6.
   PubMed Web of Science ®Google Scholar
• Tsuruda T, Kato J, Kitamura K, Kuwasako K, Imamura T, Koiwaya Y, et al. Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension 1998;31:505–10.
   PubMed Web of Science ®Google Scholar
• Proctor E, Chatamra K. High yield micronodular cirrhosis in the rat. Gastroenterology 1982;83:1183–90.
   PubMedGoogle Scholar
• Sakata J, Shimokubo T, Kitamura K, Nishizono M, Iehiki Y, Kangawa K, et al. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett 1994; 352:105–8.
   PubMed Web of Science ®Google Scholar
• Munson PJ, Rodbard D. LIGAND: a versatile computer approach for characterization of ligand binding systems. Anal Biochem 1980;107:220–39.
   PubMed Web of Science ®Google Scholar
• Kojima H, Sakurai S, Kuriyama S, Yoshiji H, Imazu H, Uemura M, et al. Endothelin-1 plays a major role in portal hypertension of biliary cirrhotic rats through endothelin receptor subtype B together with subtype A in vivo. J Hepatol 2001;34:805–11.
   PubMed Web of Science ®Google Scholar
• Owada A, Nonoguchi H, Terada Y, Marumo F, Tomita K. Microlocalization and effects of adrenomedullin in nephron segments and in mesangial cells of the rat. Am J Physiol 1997; 272:F691–7.
   Google Scholar
• Seyde WC, Longnecker DE. Anesthetic influences on regional hemodynamics in normal and hemorrhaged rats. Anesthesiology 1984;61:686–98.
   PubMed Web of Science ®Google Scholar
• Kitamura K, Kato J, Kawamoto M, Tanaka M, Chino N, Kangawa K, et al. The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem Biophys Res Commun 1998;244:551–5.
   PubMed Web of Science ®Google Scholar
• McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998; 393:333–9.
   PubMed Web of Science ®Google Scholar
• Dotsch J, Schoof E, Hanze J, Dittrich K, Opherk P, Dumke K, et al. Nitric oxide stimulates adrenomedullin secretion and gene expression in endothelial cells. Pharmacology 2002;64:135–9.
   PubMedGoogle Scholar